Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Matthias Wilhelm Beckmann (1960-)

Arzt

Name

Matthias Wilhelm Beckmann

Time

1960- (Date of birth and death)

Place

Deutschland

Academic degree

Prof. Dr.

Profession

Arzt (characteristic profession)

Variant

M. W. Beckmann
Matthias W. Beckmann
Matthias Beckmann

Further information

Prof. für Geburtshilfe und Frauenheilkunde, Leiter der Frauenklinik, Univ. Erlangen-Nürnberg

Record type

Person

GND-Identifier

112832776

Record ID

112832776

Involved in

show all

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) ��� Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

Farm structure and environmental context drive farmers’ decisions on the spatial distribution of ecological focus areas in Germany

Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy

Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study

Association of genomic variants at PAX8 and PBX2 with cervical cancer risk

Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

Role of pelvic lymph node resection in vulvar squamous cell cancer: a subset analysis of the ago-care-1 study

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study

Therapiehandbuch Gynäkologie und Geburtshilfe

Ist die Geburtseinleitung bei intrauteriner Wachstumsrestriktion und small-for-gestational-age-Feten problematisch? Eine historische Kohortenstudie

Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation

Familiärer Brust- und Eierstockkrebs : Facharzt Sprechstunde

Prevention of cervical cancer : : guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with introduction, screening and the pathology of cervical dysplasia = Prävention des Zervixkarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Register-Nummer 015/027OL, Dezember<br>2017) - Teil 1 mit Einführung, Screening und Pathologie von zervikalen Dysplasien

Prevention of cervical cancer : : guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on triage, treatment and follow-up = Prävention des Zervixkarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Register-Nummer 015/027OL, Dezember 2017) - Teil 2 mit Abklärung, Therapie und Nachbetreuung

Venöse Luftembolie bei vaginalen Verletzungen durch Geschlechtsverkehr : Kritische Analyse und Literaturübersicht zu Häufigkeit und Diagnosestellung

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) – Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women

Atlas der gynäkologischen Operationen

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Erlangen, 31.01.2017 – 243rd Statement by the German Society of Gynecology and Obstetrics (DGGG) in Response to the Call for Data on the Safety of PIP Silicone Breast Implants and the Possible Association between Breast Implants and ALCL by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) of the European Commission

CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients

Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells

State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer

The PI3K Pathway: Background and Treatment Approaches

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study

Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells

State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer

The PI3K Pathway: Background and Treatment Approaches

Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems

Atlas of breast surgery

Bevacicumab beim fortgeschrittenen Zervixkarzinom : erste zielgerichtete Therapie mit signifikantem Überlebensvorteil bei fortgeschrittenem Zervixkarzinom

Gebärmutterhalskrebs : eine Leitlinie für Patientinnen

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

Atlas of gynecologic surgery : 23 tables

Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5)

Health Economics in Breast Cancer

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

Health Economics in Breast Cancer

Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System

Therapiehandbuch Gynäkologie und Geburtshilfe

Therapiehandbuch Gynäkologie und Geburtshilfe : mit 110 Tabellen

Molekulare Medizin in der Frauenheilkunde : Diagnostik und Therapie

Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Diagnostik und Therapie der Venenthrombose und der Lungenembolie : Kurzfassung der S2-Leitlinie der AWMF

Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal